¼«ËÙÁùºÏ²Ê

Journal Article

1. Harmon KG, Pottinger PS, Baggish AL, Drezner JA, Luks AM, Thompson AA, Swaminathan S (2020). Comorbid Medical Conditions in Young Athletes: Considerations for Preparticipation Guidance During the COVID-19 Pandemic. Sports Health, 12(5), 456-458. ()
2. Verma D, Church TM, Swaminathan S (2020). Epstein-Barr virus co-opts TFIIH component XPB to specifically activate essential viral lytic promoters. Proc Natl Acad Sci U S A, 117(23), 13044-13055. ()
3. Li D, Mosbruger T, Verma D, Swaminathan S (2020). Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription. J Virol, 94(2). ()
4. Agrawal R, Durupt G, Verma D, Montgomery M, Vieira-de Abreu A, Taylor C, Swaminathan S, Fisher SJ (2019). MicroRNA-7a overexpression in VMH restores the sympathoadrenal response to hypoglycemia. JCI Insight, 4(20). ()
5. Li D, Swaminathan S (2019). Human IFIT proteins inhibit lytic replication of KSHV: A new feed-forward loop in the innate immune system. PLoS Pathog, 15(2), e1007609. ()
6. Sundermann AJ, Clancy CJ, Pasculle AW, Liu G, Cumbie RB, Driscoll E, Ayres A, Donahue L, Pergam SA, Abbo L, Andes DR, Chandrasekar P, Galdys AL, Hanson KE, Marr KA, Mayer J, Mehta S, Morris MI, Perfect J, Revankar SG, Smith B, Swaminathan S, Thompson GR, Varghese M, Vazquez J, Whimbey E, Wingard JR, Nguyen MH (2018). How Clean Is the Linen at My Hospital? The Mucorales on Unclean Linen Discovery Study of Large United States Transplant and Cancer Centers. Clin Infect Dis, 68(5), 850-853. ()
7. Fu W, Verma D, Burton A, Swaminathan S (2019). Cellular RNA Helicase DHX9 Interacts with the Essential Epstein-Barr Virus (EBV) Protein SM and Restricts EBV Lytic Replication. J Virol, 93(4). ()
8. Li D, Fu W, Swaminathan S (2018). Continuous DNA replication is required for late gene transcription and maintenance of replication compartments in gammaherpesviruses. PLoS Pathog, 14(5), e1007070. ()
9. Church TM, Verma D, Thompson J, Swaminathan S (2018). Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV. J Virol, 92(6). ()
10. Baden LR, Swaminathan S, Angarone M, Blouin G, Camins BC, Casper C, Cooper B, Dubberke ER, Engemann AM, Freifeld AG, Greene JN, Ito JI, Kaul DR, Lustberg ME, Montoya JG, Rolston K, Satyanarayana G, Segal B, Seo SK, Shoham S, Taplitz R, Topal J, Wilson JW, Hoffmann KG, Smith C (2016). Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 14(7), 882-913. ()
11. Verma D, Thompson J, Swaminathan S (2016). Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein function. Proc Natl Acad Sci U S A, 113(13), 3609-14. ()
12. Baglio SR, van Eijndhoven MA, Koppers-Lalic D, Berenguer J, Lougheed SM, Gibbs S, Lveill N, Rinkel RN, Hopmans ES, Swaminathan S, Verkuijlen SA, Scheffer GL, van Kuppeveld FJ, de Gruijl TD, Bultink IE, Jordanova ES, Hackenberg M, Piersma SR, Knol JC, Voskuyl AE, Wurdinger T, Jimnez CR, Middeldorp JM, Pegtel DM (2016). Sensing of latent EBV infection through exosomal transfer of 5'pppRNA. Proc Natl Acad Sci U S A, 113(5), E587-96. ()
13. Thompson J, Verma D, Li D, Mosbruger T, Swaminathan S (2016). Identification and Characterization of the Physiological Gene Targets of the Essential Lytic Replicative Epstein-Barr Virus SM Protein. J Virol, 90(3), 1206-21. ()
14. Verma D, Li DJ, Krueger B, Renne R, Swaminathan S (2015). Identification of the physiological gene targets of the essential lytic replicative Kaposi's sarcoma-associated herpesvirus ORF57 protein. J Virol, 89(3), 1688-702. ()
15. Li DJ, Verma D, Mosbruger T, Swaminathan S (2014). CTCF and Rad21 act as host cell restriction factors for Kaposi's sarcoma-associated herpesvirus (KSHV) lytic replication by modulating viral gene transcription. PLoS Pathog, 10(1), e1003880. ()

Case Report

1. Swaminathan P, Swaminathan S (2020). Nail Findings in Chikungunya Infection. Open Forum Infect Dis, 7(2), ofaa031. ()

Letter

1. Swaminathan S, Schlaberg R, Lewis J, Hanson KE, Couturier MR (2016). Fatal Zika Virus Infection with Secondary Nonsexual Transmission. [Letter to the editor]. N Engl J Med, 375(19), 1907-1909. ()

News

• Study Could Suggest a New Way to Control Epstein-Barr Virus
• Hidden in Plain Sight: Well-Known Drug Could Yield New Treatment for Herpes Viruses
• 10 preguntas sobre la polio
• 10 Questions About Polio
• ¿Tengo viruela del mono? Estas son las cuatro preguntas que hay que tener en cuenta
• Do I Have Monkeypox? Here Are Four Questions to Consider
• Estos son tres señales de que puede tener viruela del mono
• Here Are Three Signs You May Have Monkeypox
• Viruela del mono: Síntomas, transmisión y tratamiento
• Monkeypox: Symptoms, Transmission and Treatment
• 7 Ways to Add More Fruits and Vegetables to your Menu
• Healthy Eating: A Dietitian's Guide To A Balanced Plate
• Enhance Your Meals With These Quick Tips
• Tips for Family Meal Planning
• Choosing the Right Breast Surgeon
• Should You Take Pain Relievers Before Getting the COVID-19 Vaccine?
• La realidad sobre las vacunas COVID-19
• COVID-19 Vaccine Mythbusters
• Tip #3: Move More, 7 Ways to Move More
• Inspiring More Health, Less Medicine
• Healthy Holiday Tips
• Understanding the Dangers of Listeria
• Are Adults Protected From Measles?
• The Facts About Anthrax
• The Threat of MRSA in Sports
• Careful Who You Kiss Under the Mistletoe

Podcasts

• What Is Monkeypox and How Can You Keep Yourself Safe?
• Heart Drug Could Be Basis for New Treatment Against Epstein Barr Virus, Herpes Viruses
• How to Protect Yourself Against Infectious Diseases When Traveling Abroad
• The Difference Between Ebola in the US and In Africa